Zurich Cantonal Bank’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-17,194
| Closed | -$2.2M | – | 2557 |
|
|
2025
Q2 | $2.2M | Buy |
17,194
+190
| +1% | +$19.7K | 0.01% | 819 |
|
|
2025
Q1 | $1.51M | Buy |
17,004
+1,068
| +7% | +$104K | ﹤0.01% | 961 |
|
|
2024
Q4 | $1.39M | Buy |
15,936
+2,323
| +17% | +$213K | ﹤0.01% | 1032 |
|
|
2024
Q3 | $1.26M | Sell |
13,613
-179
| -1% | -$17.8K | ﹤0.01% | 1011 |
|
|
2024
Q2 | $1.49M | Buy |
13,792
+1,064
| +8% | +$107K | ﹤0.01% | 866 |
|
|
2024
Q1 | $1.21M | Sell |
12,728
-641
| -5% | -$55K | ﹤0.01% | 974 |
|
|
2023
Q4 | $1.23M | Buy |
13,369
+1,314
| +11% | +$85.1K | ﹤0.01% | 955 |
|
|
2023
Q3 | $605K | Buy |
12,055
+1,052
| +10% | +$56.2K | ﹤0.01% | 1278 |
|
|
2023
Q2 | $695K | Buy |
11,003
+1,421
| +15% | +$77.3K | ﹤0.01% | 1153 |
|
|
2023
Q1 | $431K | Sell |
9,582
-198
| -2% | -$8.92K | ﹤0.01% | 1383 |
|
|
2022
Q4 | $428K | Buy |
9,780
+2,131
| +28% | +$102K | ﹤0.01% | 1339 |
|
|
2022
Q3 | $504K | Hold |
7,649
| – | – | ﹤0.01% | 1186 |
|
|
2022
Q2 | $386K | Sell |
7,649
-254
| -3% | -$14.9K | ﹤0.01% | 1384 |
|
|
2022
Q1 | $505K | Sell |
7,903
-1,107
| -12% | -$79.5K | ﹤0.01% | 1320 |
|
|
2021
Q4 | $965K | Buy |
9,010
+2,561
| +40% | +$268K | ﹤0.01% | 1025 |
|
|
2021
Q3 | $663K | Sell |
6,449
-2
| -0% | -$186 | ﹤0.01% | 1118 |
|
|
2021
Q2 | $567K | Buy |
6,451
+21
| +0.3% | +$1.92K | ﹤0.01% | 1154 |
|
|
2021
Q1 | $625K | Sell |
6,430
-430
| -6% | -$42.9K | ﹤0.01% | 1082 |
|
|
2020
Q4 | $769K | Buy |
6,860
+1,276
| +23% | +$134K | ﹤0.01% | 1068 |
|
|
2020
Q3 | $518K | Hold |
5,584
| – | – | ﹤0.01% | 1078 |
|
|
2020
Q2 | $436K | Buy |
5,584
+1,984
| +55% | +$134K | ﹤0.01% | 1077 |
|
|
2020
Q1 | $211K | Buy |
3,600
+694
| +24% | +$44.7K | ﹤0.01% | 1211 |
|
|
2019
Q4 | $233K | Hold |
2,906
| – | – | ﹤0.01% | 1254 |
|
|
2019
Q3 | $214K | Buy |
2,906
+521
| +22% | +$45K | ﹤0.01% | 1210 |
|
|
2019
Q2 | $225K | Hold |
2,385
| – | – | ﹤0.01% | 1177 |
|
|
2019
Q1 | $191K | Sell |
2,385
-522
| -18% | -$38.6K | ﹤0.01% | 1209 |
|
|
2018
Q4 | $157K | Hold |
2,907
| – | – | ﹤0.01% | 1344 |
|
|
2018
Q3 | $227K | Hold |
2,907
| – | – | ﹤0.01% | 1234 |
|
|
2018
Q2 | $185K | Buy |
2,907
+492
| +20% | +$39.2K | ﹤0.01% | 1278 |
|
|
2018
Q1 | $221K | Buy |
2,415
+549
| +29% | +$47.3K | ﹤0.01% | 1142 |
|
|
2017
Q4 | $141K | Buy |
1,866
+680
| +57% | +$47.8K | ﹤0.01% | 1392 |
|
|
2017
Q3 | $83K | Hold |
1,186
| – | – | ﹤0.01% | 1501 |
|
|
2017
Q2 | $60K | Buy |
1,186
+188
| +19% | +$7.98K | ﹤0.01% | 1649 |
|
|
2017
Q1 | $40K | Buy |
+998
| New | +$35.7K | ﹤0.01% | 1895 |
|
Other funds holding BPMC
IA
HNB
Zurich Cantonal Bank's BPMC Position: Q3 2025 in Review
Zurich Cantonal Bank sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 17,194 shares — an estimated $2.2M sold.
Zurich Cantonal Bank first reported a position in BPMC in Q1 2017 and held it in 34 quarters. The position peaked at $2.2M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Zurich Cantonal Bank reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Zurich Cantonal Bank sold 17,194 Blueprint Medicines shares in Q3 2025, an estimated $2.2M.
- Zurich Cantonal Bank first reported a position in Blueprint Medicines in Q1 2017 and held it in 34 quarters.
- Zurich Cantonal Bank's Blueprint Medicines position peaked at $2.2M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Zurich Cantonal Bank's 13F filing for Q3 2025, filed 14 Nov 2025.